IDH2 and hepatocellular carcinoma: Interestingly, IDH2 is also significantly decreased in hepatocarcinoma (HCC) tissues, probably promoting the formation of metastasis due to a negative correlation with matrix metallopeptidase 9 (MMP9) [151], with a prognostic and predictive role in HCC patients [152,153].